
Intravenous immunoglobulin (IVIG) treatment modulates peripheral blood Th17 and regulatory T cells in recurrent miscarriage patients: Non randomized, open-label clinical trial
Keywords: سقط مکرر; Recurrent miscarriage; Intravenous immunoglobulin G; Treg; Th17;